Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06837181 · ClinicalTrials.gov registry record
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
A clinical trial of Diabetes and Blood Pressure, sponsored by Jaeb Center for Health Research.
- Recruiting
- Registry status
- 200
- Enrollment target
- 18
- Study locations
NCT06837181: Recruiting study of Diabetes and Blood Pressure, sponsored by Jaeb Center for Health Research.
NCT06837181 is a study of Diabetes and Blood Pressure that is actively recruiting participants, run by Jaeb Center for Health Research. The registered enrollment target is 200 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The trial reports 18 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06837181, a study of Diabetes and Blood Pressure, is actively recruiting participants, sponsored by Jaeb Center for Health Research.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 18
- Study locations
Study Summary
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Primary Outcome
To describe the rates of microvascular complications (retinopathy, nephropathy, and peripheral neuropathy) and their relationships with HbA1c and diabetes duration in diverse cohort of adolescents and adults with CFRD for ≥5 years.
Conditions Studied
Interventions
- OTHER observational study
Study Locations (18)
California
- Keck Medical Center of USC - Los Angeles
- Stanford University - Palo Alto
- University of California San Diego - San Diego
Texas
- Baylor College of Medicine - Houston
- The University of Texas Health Science Center at San Antonio - San Antonio
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado Denver - Aurora
Florida
- University of Miami - Miami
Georgia
- Emory University School of Medicine - Atlanta
Iowa
- University of Iowa - Iowa City
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-18 |
| Est. Completion | 2028-11-30 |
What NCT06837181 shows while recruiting
NCT06837181 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower).
The record links to 9 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which observational study is the first listed.
NCT06837181 lists 18 locations in 15 states (California, Texas, Alabama).
Frequently Asked Questions
What is clinical trial NCT06837181 about?
NCT06837181 is a clinical study titled "Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)". This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
What is the current status of trial NCT06837181?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-09-18. Estimated completion is 2028-11-30.
What conditions does trial NCT06837181 study?
This clinical trial studies the following conditions: Diabetes, Blood Pressure, Neuropathy, Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes.
What interventions are being tested in trial NCT06837181?
The interventions under investigation include: observational study (OTHER).
Who is sponsoring clinical trial NCT06837181?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06837181 being conducted?
This trial has 18 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06837181's enrollment target sits among peer trials
200 147th of 338 higher than 186 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI